Center for Scientific Review; Notice of Closed Meetings, 16113-16114 [2018-07679]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 72 / Friday, April 13, 2018 / Notices
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: April 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–07757 Filed 4–12–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
daltland on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Mechanisms of
Disparities for HIV-Related Co-morbidities in
Health Disparity Populations.
Date: May 30, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Minority
Health and Health Disparities, 7201
Wisconsin Ave., Suite 525, Rm. 533K,
Bethesda, MD 20814 (Telephone Conference
Call).
Contact Person: Xinli Nan, Ph.D., Scientific
Review Officer, National Institute on
Minority Health and Health Disparities,
National Institutes of Health, Scientific
VerDate Sep<11>2014
19:04 Apr 12, 2018
Jkt 244001
Review Branch, OERA, 7201 Wisconsin Ave.,
Suite 525, Bethesda, MD 20814, (301) 594–
7784, Xinli.Nan@nih.gov.
Dated: April 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–07756 Filed 4–12–18; 8:45 am]
BILLING CODE 4140–01–P
16113
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: April 10, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–07754 Filed 4–12–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Synthesis and Distribution of Drugs of Abuse
and Related Compounds (8944).
Date: April 24, 2018.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Toxicological Evaluations of Potential
Medications to Treat Drug Addiction (8939).
Date: May 15, 2018.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Chronic
Disease in the Caribbean-II.
Date: April 16, 2018.
Time: 3:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Gniesha Yvonne
Dinwiddie, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3137, Bethesda, MD 20892,
dinwiddiegy@csr.nih.gov.
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDS and
Related Research Special Topic.
Date: April 19, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
E:\FR\FM\13APN1.SGM
13APN1
16114
Federal Register / Vol. 83, No. 72 / Friday, April 13, 2018 / Notices
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR16–215:
Preclinical Research on Model Organisms to
Predict Treatment Outcomes for Disorders
Associated with Intellectual and
Developmental Disabilities.
Date: April 25, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Pat Manos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–408–
9866, manospa@csr.nih.gov.
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 9, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–07679 Filed 4–12–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
daltland on DSKBBV9HB2PROD with NOTICES
Notice of Meeting Center for Mental
Health Services
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration, (SAMHSA)
Center for Mental Health Services
(CMHS) National Advisory Council
(NAC) will meet on April 30, 2018, from
11:00 a.m. to 12:00 p.m. Eastern
Daylight Time (EDT) in a closed
teleconference meeting.
The meeting will include discussion
and evaluation of grant applications
reviewed by SAMHSA’s Initial Review
Groups, and involves an examination of
confidential financial and business
information as well as personal
information concerning the applicants.
Therefore, the meeting will be closed to
17:41 Apr 12, 2018
Jkt 244001
Committee Name: Substance Abuse and
Mental Health Services Administration,
Center for Mental Health Services National
Advisory Council.
Dates/Time/Type: Monday, April 30, 2018,
11:00 a.m. to 12:00 p.m. EDT: CLOSED.
Place: SAMHSA, 5600 Fishers Lane, 14th
Floor, Conference Room 14SEH02, Rockville,
Maryland 20857.
Contact: Pamela Foote, Designated Federal
Official, SAMHSA CMHS NAC, 5600 Fishers
Lane, Room 14E53C, Rockville, Maryland
20857, Telephone: (240) 276–1279, Fax: (301)
480–8491, Email: pamela.foote@
samhsa.hhs.gov.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2018–07693 Filed 4–12–18; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
BILLING CODE 4140–01–P
VerDate Sep<11>2014
the public as determined by the
Assistant Secretary for Mental Health
and Substance Use, in accordance with
Title 5 U.S.C. 552b(c)(4) and (6) and
Title 5 U.S.C. App. 2, 10(d).
Meeting information and a roster of
Council members may be obtained
either by accessing the SAMHSA
Council website at https://
www.samhsa.gov/about-us/advisorycouncils/cmhs-national-advisorycouncil or by contacting Ms. Pamela
Foote (see contact information below).
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project—‘‘Talk. They Hear
You.’’ Campaign Evaluation: National
Survey—NEW
SAMHSA’s Center for Substance
Abuse Prevention (CSAP) is requesting
approval from the Office of Management
and Budget (OMB) for a new data
collection, ‘‘Talk. They Hear You.’’
Campaign Evaluation: National Survey.
This collection includes two
instruments:
1. Screener
2. Survey Tool
The national survey is part of a larger
effort to evaluate the impact of the
‘‘Talk. They Hear You.’’ campaign.
These evaluations will help determine
the extent to which the campaign has
been successful in educating parents
and caregivers nationwide about
effective methods for reducing underage
drinking (UAD). The campaign is
designed to educate and empower
parents and caregivers to talk with
children about alcohol. To prevent
initiation of underage drinking, the
campaign targets parents and caregivers
of children aged 9–15, with the specific
aims of:
1. Increasing parent or caregiver
awareness of and receptivity to
campaign messages (knowledge);
2. Increasing parent or caregiver
awareness of underage drinking
prevalence (knowledge);
3. Increasing parent or caregiver
disapproval of underage drinking
(attitudes);
4. Increasing parent or caregiver
knowledge, skills, and confidence in
how to talk to their children about, and
prevent, UAD (attitudes); and
5. Increasing parent or caregiver
actions to prevent underage drinking by
talking to their children about UAD
(behaviors).
The national survey will target
parents in the base year in 2018, and
then annually in the 4 option years
following that, making this a repeat
cross-sectional research study. The
survey will be based on the survey
originally approved for use in the 2016
impact evaluation, which was designed
to quantify parent and caregiver
awareness of the campaign and
retention of campaign messages, and to
determine whether parents and
caregivers have used the campaign
materials in talking to their children.
SAMHSA will seek to conduct this
research nationwide through online
surveys. The survey will be accessible
E:\FR\FM\13APN1.SGM
13APN1
]]>Agencies
[Federal Register Volume 83, Number 72 (Friday, April 13, 2018)]
[Notices]
[Pages 16113-16114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07679]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Chronic Disease in the Caribbean-II.
Date: April 16, 2018.
Time: 3:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Gniesha Yvonne Dinwiddie, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3137, Bethesda, MD 20892,
[email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and funding
cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AIDS and Related Research Special Topic.
Date: April 19, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Robert Freund, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5216,
[[Page 16114]]
MSC 7852, Bethesda, MD 20892, 301-435-1050, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and funding
cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR16-215: Preclinical Research on Model Organisms to Predict
Treatment Outcomes for Disorders Associated with Intellectual and
Developmental Disabilities.
Date: April 25, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Pat Manos, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-408-
9866, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and funding
cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 9, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07679 Filed 4-12-18; 8:45 am]
BILLING CODE 4140-01-P
